Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Experimental Cell Research
|
May 14, 2011
CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo
Hernán G Farina, Fernando Benavent Acero, Yasser Perera, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 27, 2013
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
Georgina A Cardama, Maria J Comin, Leandro Hornos, et al.
The British Journal of Ophthalmology
|
August 29, 2018
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma
Ana V Torbidoni, Claudia Sampor, Viviana E Laurent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2013
Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA
Viviana E Laurent, Claudia Sampor, Verónica Solernou, et al.
Cancer Immunology, Immunotherapy : CII
|
June 25, 2018
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients
Valeria I Segatori, Héctor A Cuello, Cynthia A Gulino, et al.
Chemico-Biological Interactions
|
September 4, 2023
Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models
Lucia M Balsa, Luisina M Solernó, Maria R Rodriguez, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 21, 2016
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models
Fernando Benavent Acero, Carla S Capobianco, Juan Garona, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity
Yasser Perera, Hernán G Farina, Jeovanis Gil, et al.
Plos One
|
July 19, 2012
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target
Ulises D Orlando, Juan Garona, Giselle V Ripoll, et al.
Molecular Medicine Reports
|
April 8, 2011
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma
Viviana E Laurent, Laura L Otero, Valeria Vazquez, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Experimental Cell Research
|
May 14, 2011
CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo
Hernán G Farina, Fernando Benavent Acero, Yasser Perera, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 27, 2013
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
Georgina A Cardama, Maria J Comin, Leandro Hornos, et al.
The British Journal of Ophthalmology
|
August 29, 2018
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma
Ana V Torbidoni, Claudia Sampor, Viviana E Laurent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2013
Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA
Viviana E Laurent, Claudia Sampor, Verónica Solernou, et al.
Cancer Immunology, Immunotherapy : CII
|
June 25, 2018
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients
Valeria I Segatori, Héctor A Cuello, Cynthia A Gulino, et al.
Chemico-Biological Interactions
|
September 4, 2023
Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models
Lucia M Balsa, Luisina M Solernó, Maria R Rodriguez, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 21, 2016
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models
Fernando Benavent Acero, Carla S Capobianco, Juan Garona, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity
Yasser Perera, Hernán G Farina, Jeovanis Gil, et al.
Plos One
|
July 19, 2012
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target
Ulises D Orlando, Juan Garona, Giselle V Ripoll, et al.
Molecular Medicine Reports
|
April 8, 2011
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma
Viviana E Laurent, Laura L Otero, Valeria Vazquez, et al.
Page
of 10